Catalyst Biosciences, Inc. (CBIO) - Stock Prices, Stock Peers & Analysis

Home
CBIO

Company Name	Catalyst Biosciences, Inc.
Symbol	CBIO
Currency	USD
Price	0.511
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	19,418,203
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.189 - 8.694
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Nassim Usman Ph.D.
Website	https://www.catalystbiosciences.com

An error occurred while fetching data.

About Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3)